{"target":{"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","complex_id":"CHEMBL2094253","target_name":"Cyclooxygenase","target_type":"http://identifiers.org/cttv.target/protein_family","target_class":["Oxidoreductase"],"id":"http://identifiers.org/uniprot/P23219","binding_subunit_known":false},"validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","unique_association_fields":{"efo_classification":"http://www.ebi.ac.uk/efo/EFO_0000278","url":"https://clinicaltrials.gov/search?id=%22NCT03708458%22","chembl_targets":"http://identifiers.org/uniprot/P23219,http://identifiers.org/uniprot/P35354","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6","unique_id":"1"},"drug":{"withdrawn_year":null,"molecule_name":"INDOMETHACIN","withdrawn_reason":null,"molecule_type":"Small molecule","max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"id":"http://identifiers.org/chembl.compound/CHEMBL6","withdrawn_country":null},"sourceID":"chembl","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000278"},"evidence":{"drug2clinic":{"date_asserted":"2018-11-19T00:00:00.000Z","status":"Recruiting","provenance_type":{"expert":{"status":true}},"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"nice_name":"Clinical Trials Information","url":"https://clinicaltrials.gov/search?id=%22NCT03708458%22"}],"resource_score":{"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability","value":1},"clinical_trial_phase":{"numeric_index":4,"label":"Phase IV"}},"target2drug":{"is_associated":true,"resource_score":{"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"value":1},"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2094253","nice_name":"ChEMBL target information"},{"nice_name":"ISBN","url":"http://www.isbnsearch.org/isbn/9780702034718"},{"nice_name":"FDA","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/016059s097"},{"nice_name":"Other","url":"017814s040"},{"url":"018332s030lbl.pdf","nice_name":"Other"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"mechanism_of_action":"Cyclooxygenase inhibitor","date_asserted":"2015-01-14T00:00:00.000Z","action_type":"INHIBITOR","provenance_type":{"expert":{"status":true},"database":{"id":"ChEMBL","version":"23"}}}}}
{"evidence":{"target2drug":{"action_type":"INHIBITOR","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"Cyclooxygenase inhibitor","provenance_type":{"expert":{"status":true},"database":{"id":"ChEMBL","version":"23"}},"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2094253"},{"url":"http://www.isbnsearch.org/isbn/9780702034718","nice_name":"ISBN"},{"url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/016059s097","nice_name":"FDA"},{"nice_name":"Other","url":"017814s040"},{"url":"018332s030lbl.pdf","nice_name":"Other"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"]},"drug2clinic":{"resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"is_associated":true,"urls":[{"nice_name":"Clinical Trials Information","url":"https://clinicaltrials.gov/search?id=%22NCT03708458%22"}],"clinical_trial_phase":{"numeric_index":4,"label":"Phase IV"},"status":"Recruiting","provenance_type":{"expert":{"status":true}},"date_asserted":"2018-11-19T00:00:00.000Z"}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000278"},"unique_association_fields":{"chembl_targets":"http://identifiers.org/uniprot/P23219,http://identifiers.org/uniprot/P35354","unique_id":"2","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6","url":"https://clinicaltrials.gov/search?id=%22NCT03708458%22","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0000278"},"drug":{"withdrawn_country":null,"id":"http://identifiers.org/chembl.compound/CHEMBL6","max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"molecule_type":"Small molecule","withdrawn_reason":null,"molecule_name":"INDOMETHACIN","withdrawn_year":null},"sourceID":"chembl","validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","target":{"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_name":"Cyclooxygenase","target_type":"http://identifiers.org/cttv.target/protein_family","complex_id":"CHEMBL2094253","binding_subunit_known":false,"id":"http://identifiers.org/uniprot/P35354","target_class":["Oxidoreductase"]}}
{"target":{"complex_id":"CHEMBL2094253","target_name":"Cyclooxygenase","target_type":"http://identifiers.org/cttv.target/protein_family","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_class":["Oxidoreductase"],"id":"http://identifiers.org/uniprot/P23219","binding_subunit_known":false},"type":"known_drug","validated_against_schema_version":"1.2.8","access_level":"public","unique_association_fields":{"url":"https://api.fda.gov/drug/label.json?search=set_id:d470bb9f-960c-4782-a96b-e7eff6b14670","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0004274","chembl_targets":"http://identifiers.org/uniprot/P23219,http://identifiers.org/uniprot/P35354","unique_id":"3","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6"},"drug":{"withdrawn_year":null,"molecule_name":"INDOMETHACIN","molecule_type":"Small molecule","withdrawn_reason":null,"max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"id":"http://identifiers.org/chembl.compound/CHEMBL6","withdrawn_country":null},"sourceID":"chembl","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0004274"},"evidence":{"drug2clinic":{"provenance_type":{"expert":{"status":true}},"date_asserted":"2013-12-18T00:00:00.000Z","resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"nice_name":"FDA Information","url":"https://api.fda.gov/drug/label.json?search=set_id:d470bb9f-960c-4782-a96b-e7eff6b14670"}],"clinical_trial_phase":{"label":"Phase IV","numeric_index":4}},"target2drug":{"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2094253","nice_name":"ChEMBL target information"},{"nice_name":"ISBN","url":"http://www.isbnsearch.org/isbn/9780702034718"},{"nice_name":"FDA","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/016059s097"},{"url":"017814s040","nice_name":"Other"},{"url":"018332s030lbl.pdf","nice_name":"Other"}],"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"action_type":"INHIBITOR","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"Cyclooxygenase inhibitor","provenance_type":{"expert":{"status":true},"database":{"version":"23","id":"ChEMBL"}}}}}
{"drug":{"max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"id":"http://identifiers.org/chembl.compound/CHEMBL6","withdrawn_country":null,"withdrawn_year":null,"molecule_name":"INDOMETHACIN","withdrawn_reason":null,"molecule_type":"Small molecule"},"unique_association_fields":{"chembl_targets":"http://identifiers.org/uniprot/P23219,http://identifiers.org/uniprot/P35354","unique_id":"4","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0004274","url":"https://api.fda.gov/drug/label.json?search=set_id:d470bb9f-960c-4782-a96b-e7eff6b14670"},"sourceID":"chembl","type":"known_drug","validated_against_schema_version":"1.2.8","access_level":"public","target":{"binding_subunit_known":false,"id":"http://identifiers.org/uniprot/P35354","target_class":["Oxidoreductase"],"target_type":"http://identifiers.org/cttv.target/protein_family","target_name":"Cyclooxygenase","complex_id":"CHEMBL2094253","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator"},"evidence":{"target2drug":{"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2094253","nice_name":"ChEMBL target information"},{"url":"http://www.isbnsearch.org/isbn/9780702034718","nice_name":"ISBN"},{"nice_name":"FDA","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/016059s097"},{"url":"017814s040","nice_name":"Other"},{"nice_name":"Other","url":"018332s030lbl.pdf"}],"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"provenance_type":{"expert":{"status":true},"database":{"id":"ChEMBL","version":"23"}},"date_asserted":"2015-01-14T00:00:00.000Z","action_type":"INHIBITOR","mechanism_of_action":"Cyclooxygenase inhibitor"},"drug2clinic":{"date_asserted":"2013-12-18T00:00:00.000Z","provenance_type":{"expert":{"status":true}},"is_associated":true,"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"nice_name":"FDA Information","url":"https://api.fda.gov/drug/label.json?search=set_id:d470bb9f-960c-4782-a96b-e7eff6b14670"}],"clinical_trial_phase":{"label":"Phase IV","numeric_index":4}}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0004274"}}
{"target":{"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_type":"http://identifiers.org/cttv.target/single_protein","target_name":"Androgen Receptor","target_class":["Nuclear hormone receptor subfamily 3 group C member 4"],"id":"http://identifiers.org/uniprot/P10275"},"validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","drug":{"molecule_type":"Small molecule","withdrawn_reason":null,"withdrawn_year":null,"molecule_name":"BICALUTAMIDE","withdrawn_country":null,"max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"id":"http://identifiers.org/chembl.compound/CHEMBL409"},"unique_association_fields":{"chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL409","unique_id":"5","chembl_targets":"http://identifiers.org/uniprot/P10275","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0000196","url":"https://clinicaltrials.gov/search?id=%22NCT00673205%22"},"sourceID":"chembl","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000196"},"evidence":{"drug2clinic":{"status":"Completed","provenance_type":{"expert":{"status":true}},"date_asserted":"2010-12-09T00:00:00.000Z","is_associated":true,"resource_score":{"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"value":0.7},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"url":"https://clinicaltrials.gov/search?id=%22NCT00673205%22","nice_name":"Clinical Trials Information"}],"clinical_trial_phase":{"numeric_index":3,"label":"Phase III"}},"target2drug":{"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1871"},{"nice_name":"DailyMed","url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c295b64-ec39-42ec-9f02-da5b42e775e1#section-12"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"provenance_type":{"database":{"id":"ChEMBL","version":"23"},"expert":{"status":true}},"mechanism_of_action":"Androgen Receptor antagonist","date_asserted":"2015-01-14T00:00:00.000Z","action_type":"ANTAGONIST"}}}
{"evidence":{"target2drug":{"is_associated":true,"resource_score":{"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"value":1},"urls":[{"url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409","nice_name":"ChEMBL molecule information"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1871","nice_name":"ChEMBL target information"},{"url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c295b64-ec39-42ec-9f02-da5b42e775e1#section-12","nice_name":"DailyMed"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"mechanism_of_action":"Androgen Receptor antagonist","date_asserted":"2015-01-14T00:00:00.000Z","action_type":"ANTAGONIST","provenance_type":{"expert":{"status":true},"database":{"id":"ChEMBL","version":"23"}}},"drug2clinic":{"clinical_trial_phase":{"label":"Phase I","numeric_index":1},"resource_score":{"value":0.1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"is_associated":true,"urls":[{"nice_name":"Clinical Trials Information","url":"https://clinicaltrials.gov/search?id=%22NCT00328614%22"}],"status":"Completed","provenance_type":{"expert":{"status":true}},"date_asserted":"2016-10-19T00:00:00.000Z"}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0001663"},"sourceID":"chembl","drug":{"withdrawn_country":null,"id":"http://identifiers.org/chembl.compound/CHEMBL409","max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"molecule_type":"Small molecule","withdrawn_reason":null,"molecule_name":"BICALUTAMIDE","withdrawn_year":null},"unique_association_fields":{"chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL409","unique_id":"6","chembl_targets":"http://identifiers.org/uniprot/P10275","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0001663","url":"https://clinicaltrials.gov/search?id=%22NCT00328614%22"},"access_level":"public","type":"known_drug","validated_against_schema_version":"1.2.8","target":{"target_class":["Nuclear hormone receptor subfamily 3 group C member 4"],"id":"http://identifiers.org/uniprot/P10275","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_name":"Androgen Receptor","target_type":"http://identifiers.org/cttv.target/single_protein"}}
{"access_level":"public","validated_against_schema_version":"1.2.8","type":"known_drug","sourceID":"chembl","unique_association_fields":{"chembl_targets":"http://identifiers.org/uniprot/P08588","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL13","unique_id":"7","url":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b369f44-bb31-4eca-8d98-025ad18c28d5","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0000373"},"drug":{"withdrawn_country":null,"id":"http://identifiers.org/chembl.compound/CHEMBL13","max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"molecule_type":"Small molecule","withdrawn_reason":null,"molecule_name":"METOPROLOL","withdrawn_year":null},"target":{"id":"http://identifiers.org/uniprot/P08588","target_class":["Adrenergic receptor"],"target_name":"Beta-1 adrenergic receptor","target_type":"http://identifiers.org/cttv.target/single_protein","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator"},"evidence":{"drug2clinic":{"date_asserted":"2014-05-21T00:00:00.000Z","provenance_type":{"expert":{"status":true}},"clinical_trial_phase":{"numeric_index":4,"label":"Phase IV"},"is_associated":true,"resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"urls":[{"nice_name":"DailyMed Information","url":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b369f44-bb31-4eca-8d98-025ad18c28d5"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"]},"target2drug":{"provenance_type":{"database":{"id":"ChEMBL","version":"23"},"expert":{"status":true}},"mechanism_of_action":"Beta-1 adrenergic receptor antagonist","date_asserted":"2015-01-14T00:00:00.000Z","action_type":"ANTAGONIST","resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL213","nice_name":"ChEMBL target information"},{"nice_name":"DailyMed","url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3817543-544a-4afa-ac7c-c1b48c1307c2"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"]}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000373"}}
{"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000537"},"evidence":{"target2drug":{"is_associated":true,"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL213"},{"nice_name":"DailyMed","url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31d8610a-ab22-49e5-a762-6b08244ee93a"}],"provenance_type":{"database":{"version":"23","id":"ChEMBL"},"expert":{"status":true}},"mechanism_of_action":"Beta-1 adrenergic receptor antagonist","date_asserted":"2015-01-14T00:00:00.000Z","action_type":"ANTAGONIST"},"drug2clinic":{"status":"Terminated","provenance_type":{"expert":{"status":true}},"date_asserted":"2014-09-16T00:00:00.000Z","clinical_trial_phase":{"numeric_index":4,"label":"Phase IV"},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"urls":[{"nice_name":"Clinical Trials Information","url":"https://clinicaltrials.gov/search?id=%22NCT02242812%22"}]}},"target":{"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_name":"Beta-1 adrenergic receptor","target_type":"http://identifiers.org/cttv.target/single_protein","id":"http://identifiers.org/uniprot/P08588","target_class":["Adrenergic receptor"]},"access_level":"public","validated_against_schema_version":"1.2.8","type":"known_drug","sourceID":"chembl","drug":{"withdrawn_reason":null,"molecule_type":"Small molecule","molecule_name":"METOPROLOL","withdrawn_year":null,"withdrawn_country":null,"id":"http://identifiers.org/chembl.compound/CHEMBL13","max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4}},"unique_association_fields":{"url":"https://clinicaltrials.gov/search?id=%22NCT02242812%22","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0000537","chembl_targets":"http://identifiers.org/uniprot/P08588","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL13","unique_id":"8"}}
{"evidence":{"target2drug":{"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"is_associated":true,"urls":[{"url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413","nice_name":"ChEMBL molecule information"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1902"},{"url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc#section-14","nice_name":"DailyMed"}],"provenance_type":{"database":{"id":"ChEMBL","version":"23"},"expert":{"status":true}},"action_type":"INHIBITOR","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"FK506-binding protein 1A inhibitor"},"drug2clinic":{"provenance_type":{"expert":{"status":true}},"status":"Completed","date_asserted":"2016-03-28T00:00:00.000Z","clinical_trial_phase":{"numeric_index":1,"label":"Phase I"},"urls":[{"url":"https://clinicaltrials.gov/search?id=%22NCT02724332%22","nice_name":"Clinical Trials Information"}],"resource_score":{"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"value":0.1},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"is_associated":true}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000182"},"unique_association_fields":{"unique_id":"9","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL413","chembl_targets":"http://identifiers.org/uniprot/P62942","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0000182","url":"https://clinicaltrials.gov/search?id=%22NCT02724332%22"},"drug":{"withdrawn_country":null,"id":"http://identifiers.org/chembl.compound/CHEMBL413","max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"withdrawn_reason":null,"molecule_type":"Small molecule","molecule_name":"SIROLIMUS","withdrawn_year":null},"sourceID":"chembl","validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","target":{"id":"http://identifiers.org/uniprot/P62942","target_class":["Isomerase"],"target_type":"http://identifiers.org/cttv.target/single_protein","target_name":"FK506-binding protein 1A","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator"}}
{"target":{"id":"http://identifiers.org/uniprot/P00915","target_class":["Lyase"],"target_type":"http://identifiers.org/cttv.target/single_protein","target_name":"Carbonic anhydrase I","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator"},"type":"known_drug","validated_against_schema_version":"1.2.8","access_level":"public","drug":{"max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"id":"http://identifiers.org/chembl.compound/CHEMBL20","withdrawn_country":null,"withdrawn_year":null,"molecule_name":"ACETAZOLAMIDE","withdrawn_reason":null,"molecule_type":"Small molecule"},"unique_association_fields":{"chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL20","unique_id":"10","chembl_targets":"http://identifiers.org/uniprot/P00915","efo_classification":"http://www.ebi.ac.uk/efo/EFO_1000782","url":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=218bf305-0bd6-4a84-8936-76f88aa894f7"},"sourceID":"chembl","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_1000782"},"evidence":{"drug2clinic":{"urls":[{"nice_name":"DailyMed Information","url":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=218bf305-0bd6-4a84-8936-76f88aa894f7"}],"is_associated":true,"resource_score":{"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability","value":1},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"clinical_trial_phase":{"label":"Phase IV","numeric_index":4},"provenance_type":{"expert":{"status":true}},"date_asserted":"2011-11-15T00:00:00.000Z"},"target2drug":{"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL261","nice_name":"ChEMBL target information"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"is_associated":true,"provenance_type":{"expert":{"status":true},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/10713865"},{"lit_id":"http://europepmc.org/abstract/MED/18336310"}]},"database":{"id":"ChEMBL","version":"23"}},"action_type":"INHIBITOR","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"Carbonic anhydrase I inhibitor"}}}
{"unique_association_fields":{"chembl_targets":"http://identifiers.org/uniprot/O60840,http://identifiers.org/uniprot/Q01668,http://identifiers.org/uniprot/Q13698,http://identifiers.org/uniprot/Q13936","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6966","unique_id":"11","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003843","url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22"},"drug":{"withdrawn_year":null,"molecule_name":"VERAPAMIL","withdrawn_reason":null,"molecule_type":"Small molecule","max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"id":"http://identifiers.org/chembl.compound/CHEMBL6966","withdrawn_country":null},"sourceID":"chembl","type":"known_drug","validated_against_schema_version":"1.2.8","access_level":"public","target":{"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_type":"http://identifiers.org/cttv.target/protein_family","target_name":"Voltage-gated L-type calcium channel","complex_id":"CHEMBL2095229","binding_subunit_known":false,"id":"http://identifiers.org/uniprot/O60840","target_class":["Voltage-gated calcium channel"]},"evidence":{"drug2clinic":{"clinical_trial_phase":{"label":"Phase II","numeric_index":2},"resource_score":{"value":0.2,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"nice_name":"Clinical Trials Information","url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22"}],"date_asserted":"2017-04-24T00:00:00.000Z","provenance_type":{"expert":{"status":true}},"status":"Terminated"},"target2drug":{"provenance_type":{"database":{"id":"ChEMBL","version":"23"},"expert":{"status":true}},"mechanism_of_action":"Voltage-gated L-type calcium channel blocker","date_asserted":"2015-01-14T00:00:00.000Z","action_type":"BLOCKER","urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6966"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2095229"},{"nice_name":"ISBN","url":"http://www.isbnsearch.org/isbn/9780702034718"},{"nice_name":"FDA","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018817s027lbl.pdf"}],"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"is_associated":true}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003843"}}
{"evidence":{"drug2clinic":{"provenance_type":{"expert":{"status":true}},"status":"Terminated","date_asserted":"2017-04-24T00:00:00.000Z","resource_score":{"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"value":0.2},"is_associated":true,"urls":[{"nice_name":"Clinical Trials Information","url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"clinical_trial_phase":{"numeric_index":2,"label":"Phase II"}},"target2drug":{"is_associated":true,"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6966"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2095229"},{"nice_name":"ISBN","url":"http://www.isbnsearch.org/isbn/9780702034718"},{"nice_name":"FDA","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018817s027lbl.pdf"}],"action_type":"BLOCKER","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"Voltage-gated L-type calcium channel blocker","provenance_type":{"expert":{"status":true},"database":{"version":"23","id":"ChEMBL"}}}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003843"},"unique_association_fields":{"efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003843","url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6966","unique_id":"12","chembl_targets":"http://identifiers.org/uniprot/O60840,http://identifiers.org/uniprot/Q01668,http://identifiers.org/uniprot/Q13698,http://identifiers.org/uniprot/Q13936"},"drug":{"withdrawn_year":null,"molecule_name":"VERAPAMIL","withdrawn_reason":null,"molecule_type":"Small molecule","max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"id":"http://identifiers.org/chembl.compound/CHEMBL6966","withdrawn_country":null},"sourceID":"chembl","type":"known_drug","validated_against_schema_version":"1.2.8","access_level":"public","target":{"target_name":"Voltage-gated L-type calcium channel","complex_id":"CHEMBL2095229","target_type":"http://identifiers.org/cttv.target/protein_family","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","binding_subunit_known":false,"id":"http://identifiers.org/uniprot/Q01668","target_class":["Voltage-gated calcium channel"]}}
{"access_level":"public","type":"known_drug","validated_against_schema_version":"1.2.8","sourceID":"chembl","drug":{"molecule_type":"Small molecule","withdrawn_reason":null,"withdrawn_year":null,"molecule_name":"VERAPAMIL","withdrawn_country":null,"max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"id":"http://identifiers.org/chembl.compound/CHEMBL6966"},"unique_association_fields":{"url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003843","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6966","unique_id":"13","chembl_targets":"http://identifiers.org/uniprot/O60840,http://identifiers.org/uniprot/Q01668,http://identifiers.org/uniprot/Q13698,http://identifiers.org/uniprot/Q13936"},"target":{"target_type":"http://identifiers.org/cttv.target/protein_family","target_name":"Voltage-gated L-type calcium channel","complex_id":"CHEMBL2095229","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_class":["Voltage-gated calcium channel"],"id":"http://identifiers.org/uniprot/Q13698","binding_subunit_known":false},"evidence":{"target2drug":{"mechanism_of_action":"Voltage-gated L-type calcium channel blocker","action_type":"BLOCKER","date_asserted":"2015-01-14T00:00:00.000Z","provenance_type":{"database":{"version":"23","id":"ChEMBL"},"expert":{"status":true}},"urls":[{"url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6966","nice_name":"ChEMBL molecule information"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2095229"},{"url":"http://www.isbnsearch.org/isbn/9780702034718","nice_name":"ISBN"},{"url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018817s027lbl.pdf","nice_name":"FDA"}],"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"]},"drug2clinic":{"status":"Terminated","provenance_type":{"expert":{"status":true}},"date_asserted":"2017-04-24T00:00:00.000Z","clinical_trial_phase":{"label":"Phase II","numeric_index":2},"is_associated":true,"resource_score":{"value":0.2,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22","nice_name":"Clinical Trials Information"}]}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003843"}}
{"target":{"id":"http://identifiers.org/uniprot/Q13936","target_class":["Voltage-gated calcium channel"],"binding_subunit_known":false,"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_type":"http://identifiers.org/cttv.target/protein_family","target_name":"Voltage-gated L-type calcium channel","complex_id":"CHEMBL2095229"},"type":"known_drug","validated_against_schema_version":"1.2.8","access_level":"public","drug":{"withdrawn_country":null,"max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"id":"http://identifiers.org/chembl.compound/CHEMBL6966","withdrawn_reason":null,"molecule_type":"Small molecule","withdrawn_year":null,"molecule_name":"VERAPAMIL"},"unique_association_fields":{"unique_id":"14","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL6966","chembl_targets":"http://identifiers.org/uniprot/O60840,http://identifiers.org/uniprot/Q01668,http://identifiers.org/uniprot/Q13698,http://identifiers.org/uniprot/Q13936","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003843","url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22"},"sourceID":"chembl","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003843"},"evidence":{"target2drug":{"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6966"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL2095229","nice_name":"ChEMBL target information"},{"nice_name":"ISBN","url":"http://www.isbnsearch.org/isbn/9780702034718"},{"nice_name":"FDA","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018817s027lbl.pdf"}],"resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"is_associated":true,"provenance_type":{"expert":{"status":true},"database":{"id":"ChEMBL","version":"23"}},"date_asserted":"2015-01-14T00:00:00.000Z","action_type":"BLOCKER","mechanism_of_action":"Voltage-gated L-type calcium channel blocker"},"drug2clinic":{"date_asserted":"2017-04-24T00:00:00.000Z","status":"Terminated","provenance_type":{"expert":{"status":true}},"clinical_trial_phase":{"numeric_index":2,"label":"Phase II"},"resource_score":{"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"value":0.2},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"nice_name":"Clinical Trials Information","url":"https://clinicaltrials.gov/search?id=%22NCT02209155%22"}],"is_associated":true}}}
{"evidence":{"drug2clinic":{"clinical_trial_phase":{"label":"Phase IV","numeric_index":4},"resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"is_associated":true,"urls":[{"nice_name":"DailyMed Information","url":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99ae0271-47d8-4321-96e0-55124811df1a"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"date_asserted":"2013-03-29T00:00:00.000Z","provenance_type":{"expert":{"status":true}}},"target2drug":{"resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL213","nice_name":"ChEMBL target information"},{"nice_name":"DailyMed","url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f36d4ed3-dcbb-4465-9fa6-1da811f555e6"}],"provenance_type":{"expert":{"status":true},"database":{"version":"23","id":"ChEMBL"}},"date_asserted":"2015-01-14T00:00:00.000Z","action_type":"ANTAGONIST","mechanism_of_action":"Beta-1 adrenergic receptor antagonist"}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003913"},"drug":{"molecule_type":"Small molecule","withdrawn_reason":null,"withdrawn_year":null,"molecule_name":"ATENOLOL","withdrawn_country":null,"max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"id":"http://identifiers.org/chembl.compound/CHEMBL24"},"unique_association_fields":{"chembl_targets":"http://identifiers.org/uniprot/P08588","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL24","unique_id":"15","url":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99ae0271-47d8-4321-96e0-55124811df1a","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003913"},"sourceID":"chembl","validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","target":{"id":"http://identifiers.org/uniprot/P08588","target_class":["Adrenergic receptor"],"target_type":"http://identifiers.org/cttv.target/single_protein","target_name":"Beta-1 adrenergic receptor","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator"}}
{"target":{"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_name":"Beta-2 adrenergic receptor","target_type":"http://identifiers.org/cttv.target/single_protein","target_class":["Adrenergic receptor"],"id":"http://identifiers.org/uniprot/P07550"},"validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","drug":{"withdrawn_country":null,"max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"id":"http://identifiers.org/chembl.compound/CHEMBL27","withdrawn_reason":null,"molecule_type":"Small molecule","withdrawn_year":null,"molecule_name":"PROPRANOLOL"},"unique_association_fields":{"efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003821","url":"https://api.fda.gov/drug/label.json?search=set_id:1431ca79-5995-46c2-a16f-882ed7bc43ca","unique_id":"16","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL27","chembl_targets":"http://identifiers.org/uniprot/P07550"},"sourceID":"chembl","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003821"},"evidence":{"drug2clinic":{"clinical_trial_phase":{"label":"Phase IV","numeric_index":4},"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"is_associated":true,"urls":[{"url":"https://api.fda.gov/drug/label.json?search=set_id:1431ca79-5995-46c2-a16f-882ed7bc43ca","nice_name":"FDA Information"}],"date_asserted":"2011-06-03T00:00:00.000Z","provenance_type":{"expert":{"status":true}}},"target2drug":{"urls":[{"url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27","nice_name":"ChEMBL molecule information"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL210"},{"nice_name":"Wikipedia","url":"http://en.wikipedia.org/wiki/Propranolol"},{"url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c","nice_name":"DailyMed"}],"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"resource_score":{"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability","value":1},"action_type":"ANTAGONIST","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"Beta-2 adrenergic receptor antagonist","provenance_type":{"expert":{"status":true},"database":{"version":"23","id":"ChEMBL"}}}}}
{"sourceID":"chembl","unique_association_fields":{"chembl_targets":"http://identifiers.org/uniprot/P51649","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL109","unique_id":"17","efo_classification":"http://www.orpha.net/ORDO/Orphanet_83419","url":"https://clinicaltrials.gov/search?id=%22NCT00481013%22"},"drug":{"id":"http://identifiers.org/chembl.compound/CHEMBL109","max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"withdrawn_country":null,"molecule_name":"VALPROIC ACID","withdrawn_year":null,"withdrawn_reason":null,"molecule_type":"Small molecule"},"access_level":"public","type":"known_drug","validated_against_schema_version":"1.2.8","target":{"id":"http://identifiers.org/uniprot/P51649","target_class":["Oxidoreductase"],"target_name":"Succinate semialdehyde dehydrogenase","target_type":"http://identifiers.org/cttv.target/single_protein","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator"},"evidence":{"drug2clinic":{"status":"Completed","provenance_type":{"expert":{"status":true}},"date_asserted":"2016-12-05T00:00:00.000Z","urls":[{"url":"https://clinicaltrials.gov/search?id=%22NCT00481013%22","nice_name":"Clinical Trials Information"}],"is_associated":true,"resource_score":{"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability","value":0.2},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"clinical_trial_phase":{"label":"Phase II","numeric_index":2}},"target2drug":{"is_associated":true,"resource_score":{"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability","value":1},"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1911","nice_name":"ChEMBL target information"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"action_type":"INHIBITOR","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"Succinate semialdehyde dehydrogenase inhibitor","provenance_type":{"database":{"version":"23","id":"ChEMBL"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/10812195"}]},"expert":{"status":true}}}},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_83419"}}
{"evidence":{"target2drug":{"provenance_type":{"database":{"version":"23","id":"ChEMBL"},"expert":{"status":true}},"action_type":"INHIBITOR","date_asserted":"2015-01-14T00:00:00.000Z","mechanism_of_action":"Thiazide-sensitive sodium-chloride cotransporter inhibitor","resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"is_associated":true,"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1876","nice_name":"ChEMBL target information"},{"url":"http://www.nejm.org/doi/full/10.1056/NEJMra0907219","nice_name":"DOI"},{"nice_name":"DailyMed","url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7efb04ae-3d39-4853-9741-466c8973e8b2"},{"url":"http://en.wikipedia.org/wiki/Diuretic","nice_name":"Wikipedia"},{"url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020125s020lbl.pdf","nice_name":"FDA"},{"nice_name":"Wikipedia","url":"http://en.wikipedia.org/wiki/Hydrochlorothiazide"}],"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"]},"drug2clinic":{"resource_score":{"value":1,"method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"type":"probability"},"is_associated":true,"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"urls":[{"url":"https://clinicaltrials.gov/search?id=%22NCT02875886%22","nice_name":"Clinical Trials Information"}],"clinical_trial_phase":{"label":"Phase IV","numeric_index":4},"provenance_type":{"expert":{"status":true}},"status":"Completed","date_asserted":"2016-09-06T00:00:00.000Z"}},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003884"},"drug":{"max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"id":"http://identifiers.org/chembl.compound/CHEMBL435","withdrawn_country":null,"withdrawn_year":null,"molecule_name":"HYDROCHLOROTHIAZIDE","molecule_type":"Small molecule","withdrawn_reason":null},"unique_association_fields":{"efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003884","url":"https://clinicaltrials.gov/search?id=%22NCT02875886%22","unique_id":"18","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL435","chembl_targets":"http://identifiers.org/uniprot/P55017"},"sourceID":"chembl","validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","target":{"id":"http://identifiers.org/uniprot/P55017","target_class":["SLC12 family of cation-coupled chloride transporters"],"activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","target_name":"Thiazide-sensitive sodium-chloride cotransporter","target_type":"http://identifiers.org/cttv.target/single_protein"}}
{"target":{"target_name":"Thiazide-sensitive sodium-chloride cotransporter","target_type":"http://identifiers.org/cttv.target/single_protein","activity":"http://identifiers.org/cttv.activity/drug_negative_modulator","id":"http://identifiers.org/uniprot/P55017","target_class":["SLC12 family of cation-coupled chloride transporters"]},"validated_against_schema_version":"1.2.8","type":"known_drug","access_level":"public","drug":{"withdrawn_country":null,"id":"http://identifiers.org/chembl.compound/CHEMBL435","max_phase_for_all_diseases":{"numeric_index":4,"label":"Phase IV"},"molecule_type":"Small molecule","withdrawn_reason":null,"molecule_name":"HYDROCHLOROTHIAZIDE","withdrawn_year":null},"unique_association_fields":{"chembl_targets":"http://identifiers.org/uniprot/P55017","unique_id":"19","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL435","efo_classification":"http://www.ebi.ac.uk/efo/EFO_0004255","url":"https://api.fda.gov/drug/label.json?search=set_id:7f7d3112-266f-47b6-85f7-a6a689f88b4d"},"sourceID":"chembl","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0004255"},"evidence":{"drug2clinic":{"date_asserted":"2013-10-09T00:00:00.000Z","provenance_type":{"expert":{"status":true}},"clinical_trial_phase":{"label":"Phase IV","numeric_index":4},"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"is_associated":true,"urls":[{"url":"https://api.fda.gov/drug/label.json?search=set_id:7f7d3112-266f-47b6-85f7-a6a689f88b4d","nice_name":"FDA Information"}]},"target2drug":{"mechanism_of_action":"Thiazide-sensitive sodium-chloride cotransporter inhibitor","action_type":"INHIBITOR","date_asserted":"2015-01-14T00:00:00.000Z","provenance_type":{"expert":{"status":true},"database":{"id":"ChEMBL","version":"23"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"is_associated":true,"urls":[{"url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435","nice_name":"ChEMBL molecule information"},{"url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1876","nice_name":"ChEMBL target information"},{"url":"http://www.nejm.org/doi/full/10.1056/NEJMra0907219","nice_name":"DOI"},{"url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7efb04ae-3d39-4853-9741-466c8973e8b2","nice_name":"DailyMed"},{"nice_name":"Wikipedia","url":"http://en.wikipedia.org/wiki/Diuretic"},{"url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020125s020lbl.pdf","nice_name":"FDA"},{"nice_name":"Wikipedia","url":"http://en.wikipedia.org/wiki/Hydrochlorothiazide"}]}}}
{"target":{"target_type":"http://identifiers.org/cttv.target/single_protein","target_name":"Serotonin 1d (5-HT1d) receptor","activity":"http://identifiers.org/cttv.activity/drug_positive_modulator","id":"http://identifiers.org/uniprot/P28221","target_class":["Serotonin receptor"]},"sourceID":"chembl","drug":{"withdrawn_year":null,"molecule_name":"ERGOTAMINE","molecule_type":"Small molecule","withdrawn_reason":null,"max_phase_for_all_diseases":{"label":"Phase IV","numeric_index":4},"id":"http://identifiers.org/chembl.compound/CHEMBL442","withdrawn_country":null},"unique_association_fields":{"efo_classification":"http://www.ebi.ac.uk/efo/EFO_0003821","url":"https://api.fda.gov/drug/label.json?search=set_id:ed1ede57-1317-491a-9ebb-edee9aef5b3b","chembl_molecules":"http://identifiers.org/chembl.compound/CHEMBL442","unique_id":"20","chembl_targets":"http://identifiers.org/uniprot/P28221"},"access_level":"public","type":"known_drug","validated_against_schema_version":"1.2.8","disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0003821"},"evidence":{"drug2clinic":{"is_associated":true,"urls":[{"url":"https://api.fda.gov/drug/label.json?search=set_id:ed1ede57-1317-491a-9ebb-edee9aef5b3b","nice_name":"FDA Information"}],"resource_score":{"value":1,"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"}},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/drug_disease"],"clinical_trial_phase":{"numeric_index":4,"label":"Phase IV"},"provenance_type":{"expert":{"status":true}},"date_asserted":"2010-06-29T00:00:00.000Z"},"target2drug":{"date_asserted":"2015-01-14T00:00:00.000Z","action_type":"AGONIST","mechanism_of_action":"Serotonin 1d (5-HT1d) receptor agonist","provenance_type":{"expert":{"status":true},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/10611116"}]},"database":{"id":"ChEMBL","version":"23"}},"resource_score":{"type":"probability","method":{"url":"https://github.com/CTTV/association_score_methods/blob/master/CTTV008_ChEMBL/description.md"},"value":1},"evidence_codes":["http://purl.obolibrary.org/obo/ECO_0000205","http://identifiers.org/eco/target_drug"],"is_associated":true,"urls":[{"nice_name":"ChEMBL molecule information","url":"https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442"},{"nice_name":"ChEMBL target information","url":"https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1983"},{"url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1","nice_name":"DailyMed"},{"nice_name":"EuropePMC","url":"http://europepmc.org/abstract/MED/10611116"},{"nice_name":"ISBN","url":"http://www.isbnsearch.org/isbn/0443059748"}]}}}
